The need for additional safeguards in the informed consent process in schizophrenia research
- PMID: 17971467
- PMCID: PMC2598106
- DOI: 10.1136/jme.2006.017376
The need for additional safeguards in the informed consent process in schizophrenia research
Abstract
The process of obtaining informed consent to participate in a clinical study presents many challenges for research conducted in a population of patients with schizophrenia. Morally valid, informed consent must include information sharing, decisional capacity, and capacity for voluntarism. This paper examines the unique features of schizophrenia that may threaten each of these elements of informed consent, and it proposes additional safeguards in the process of gaining informed consent from individuals with schizophrenia in order to maximise the decision-making potential of this patient population.
Conflict of interest statement
Competing interests: None declared.
References
-
- Duval G. Ethics in psychiatric research: study design issues. Can J Psychiatry 20044955–59. - PubMed
-
- Osborn D P. Research and ethics: leaving exclusion behind. Curr Opin Psychiatry 199912601–604. - PubMed
-
- Levine R J. Consent issues in human research. In: Emanuel EJ, Crouch RA, Arras JD, et al eds. Ethical and regulatory aspects of clinical research: readings and commentary. Baltimore, MD: Johns Hopkins University Press, 2003197–201.
-
- American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM‐IV‐TR. 4th edn, text revision. Washington, DC: American Psychiatric Association, 2000
MeSH terms
LinkOut - more resources
Full Text Sources
Medical